The Brief Introduction Of CAR-T Cell Therapy in Cancer Tumors

Abstract

CAR-T cell therapy shows revolutionary promises in the therapeutic treatment of cancer, offering the possibility of long-lasting remissions and potential cures for certain cancers. The principle of this immunotherapy is to improve patient's own T cells. It shows clinically significant efficacy in difficult-to-treat cancers. However, when overcoming solid tumors, this therapy encounters limitations of tumor infiltration, the multiple limitations of the tumor microenvironment, and the toxicity produced by CAR-T cells themselves. All these factors make the efficacy of CAR-T cell immunotherapy significantly reduced. The investigation of the causes leading to these issues is a central focus of research. The focus of this paper is on the accomplishments made in CAR-T cell therapy and the drugs that are currently available on the market. It will also cover current shortcomings of this immunotherapy and difficulties that need to be overcome. The paper will also cover a vision and prediction of future CAR-T cell therapy technology.